Dr. Lopez-Jimenez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
- Universidad Autonoma de Nicaragua Faculty of MedicineClass of 1990
Certifications & Licensure
- MN State Medical License 2001 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- Glucagon-Like Peptide-1 Agonist Use in Adults With Congenital Heart Disease: Effect, Safety, and Outcomes.Rashmi Thapa, Kyla M Lara-Breitinger, Francisco Lopez-Jimenez, Nishat Shama, Alexander C Egbe
JACC. Advances. 2025-03-24 - Artificial Intelligence ECG Diastolic Dysfunction and Survival in Cardiac Intensive Care Unit Patients.Jacob C Jentzer, Eunjung Lee, Zachi Attia, Dustin Hillerson, Garvan C Kane
Journal of the American Heart Association. 2025-03-04 - Author Correction: Artificial intelligence guided screening for cardiomyopathies in an obstetric population: a pragmatic randomized clinical trial.Demilade A Adedinsewo, Andrea Carolina Morales-Lara, Bosede B Afolabi, Oyewole A Kushimo, Amam C Mbakwem
Nature Medicine. 2025-02-04
Press Mentions
- New Research Links Mediterranean Diet to Long COVID Relief—Mayo Clinic Takes It FurtherFebruary 18th, 2025
- Simple Heart Health Tips from Dr. Lopez-Jimenez to Prevent Heart DiseaseFebruary 18th, 2025
- Better Than BMI? 3D Body Scanner Uses AI to Measure Metabolic HealthAugust 23rd, 2024
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: